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Long-term Cholinergic Denervation caused by Early 
Postnatal AF64A Lesion Prevents Development of 
Muscarinic Receptors in Rat Hippocampus 
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A. Donny Strosberg§ and Csaba Nyakast~ 
tDepartment ofAnimal Physiology, University of Groningen, Haren, The Netherlands 
~Central Research Division, Postgraduate Medical School, Budapest, Hungary 
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ABSTRACT 
The effect of early postnatal (day 8) intracerebroventricular injections of the putative cholinotoxin 
ethylcholine aziridinium mustard (AF64A) on development of cholinergic innervation and post- 
synaptic muscarinic acetylcholine receptors in the rathippocampus was examined. Th  cholinotoxin 
applied at this stage of development leads to a permanent denervation of cholinergic fibres in the 
hippocampus inadulthood demonstrated by (immuno)histochemical methods and biochemical assays. 
Muscarinic receptor expression in the principal neurons of dentate gyrus and cornu ammonis was 
strongly reduced as studied by immunostaining with antibodies against muscarinic receptor proteins 
and binding assays with themuscarinic antagonist quinuclidinyl benzilate. Cholinoceptive interneurons 
and somatostatinergic interneurons are not aff cted by the developmental cholinergic lesion. Immuno- 
reactivity to protein kinase C type I as a marker for inositolphosphate-related cellular activation 
systems slightly decreased in the apical dendrites of the hippocampal principal neurons. These findings 
indicate that damage to ingrowing cholinergic terminals in the hippocampus in the early postnatal 
period is a critical hazard for development of the muscarinic receptor system in he hippocampal 
principal neurons. These results are discussed for their significance to the neural mechanisms that 
underlie perinatal brain d mage and associated cognitive dysfunction. 
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INTRODUCTION 
In recent papers we reported the effects of pre- 
and early postnatal hypoxia nd anoxia in the rat on 
the development of serotonergic and cholinergic 
system development in cortex and hippocampus 
(Nyakas et al., 1989). Furthermore, the effects of the 
perinatal hypoxic treatment were assessed on devel- 
opment of cognitive and motivational behaviours in
which the above-mentioned forebrain transmitter 
systems and their receptors play a prominent role 
(Deutch, 1971; Whishaw et al., 1985; Altman et al., 
1987; Nakahara et al., 1989; Nyakas et al., 1990, 
1991). It was demonstrated that hypoxic events in 
the perinatal period yield a suppression ofingrowth 
of cholinergic and serotonergic fibres in cortex and 
hippocampus during their development in the first 
2 weeks after birth. Littermates receiving the same 
treatment revealed a severe malfunction of open- 
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field motor behaviours and of learning and memory 
performance (Nyakas et al., 1989, 1990, 1991). 
This coincidence of neuropathologic damage to 
hippocampal nd cortical systems and hippocampal 
behavioural functions after hypoxia suggests causal 
relationships between these affected systems and 
abnormal behavioural function. Hypoxia and 
anoxia, however, exert a rather general effect on the 
developing nervous system, although some areas 
like cortex and hippocampus are more susceptible 
to hypoxia than others (Siesj6 and Plum, 1973; 
Fenichel, 1980; Onodera et al., 1987; Mudrick and 
Baimbridge, 1989; Represa et al., 1989; Choi, 1990; 
Vannucci, 1990). Furthermore, hypoxia nd ischae- 
mia have a reported epressive effect on synthesis of 
cholinergic enzymes and influence receptor density 
in the developing brain (Gibson and Duffy, 1981; 
Gross et al., 1981; Hershkowitz et al., 1983; Speiser 
et al., 1986). 
The present experiments were undertaken togain 
further insight in the effect of specific cholinergic 
lesions in the perinatal period on the development 
of the muscarinic acetylcholine r ceptor (mAChR). 
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This development of mAChR has our particular 
interest since it plays a key role in learning pro- 
cesses and other cognitive functions (Deutch, 1971; 
Whishaw et al., 1985; Mudrick and Baimbridge, 
1989). To this aim we investigated evelopmen- 
tal effects of specific cholinergic lesions in the 
hippocampus in the early postnatal period. The 
lesions were obtained by intracerebroventricular 
(i.c.v.) injections of the cholinotoxin ethylcholine 
aziridinium mustard (AF64A), which at low doses 
and in certain experimental conditions is a selec- 
tive toxin to hippocampal cholinergic innervation 
(Fisher et al., 1982; K~sa et al., 1986; Potter et al., 
1986). With such a tool we aimed to assess the effects 
of specific damage to growing cholinergic fibres 
and development ofmAChR receptors inthe hippo- 
campus. In this paper we will report on the long- 
term effect of early postnatal lesion on development 
of(l) hippocampal cholinergic innervation, (2) post- 
synaptic muscarinic receptors, (3) protein kinase C 
(PKC) immunoreactivity, and (4) somatostatinergic 
innervation of the hippocampus. PKC was studied 
because of the intimate functional relations of this 
enzyme with muscarinic receptors (Haga et al., 1990; 
Strosberg, 1991). Somatostatin (SOM) immuno- 
staining was investigated in view of the close 
anatomical contacts between septo-hippocampal 
projections and SOM-positive target interneurons 
in the hippocampus (Yamano and Luiten, 1989) 
and the recently demonstrated colocalization of 
mAChR and SOM in such cells (Van der Zee et al., 
1991). Effects of perinatal AF64A lesion on devel- 
opment of cognitive behavioural performance will 
be described in a separate report. Part of the current 
data were recently presented in abstract form 
elsewhere (Luiten et al., 1990). 
MATERIALS AND METHODS 
Lesioning procedure with AF64A 
For the present investigation, 37 male Wistar pups 
were injected with the cholinotoxin AF64A (RBI, 
Natick, USA) or the vehicle solution. Before injec- 
tion, the acetyl ethylcholine mustard was subjected 
to basic hydrolysis and subsequent transition into 
an aziridinium ion as described by Potter et al. 
(1986). At postnatal day 8, randomly selected pups 
from various nests were lightly but adequately 
anaesthetized with ether for approximately 10min. 
The drug was injected bilaterally over a period of 
5 min per injection for each side of the brain. The 
deposits were carried out with a 5 lal Hamilton 
syringe adjusted to the micromanipulator f a 
stereotaxic instrument. The tip of the injection 
needle was aimed at the lateral ventricles at stereo- 
tactic oordinates relative to bregma AP 0.0, L_  1.4 
and V 4.0. The ventral coordinate was measured 
from the surface of the skull. AF64A was delivered 
at an optimal dose of2.0 nmol in 2 ~1 buffered saline 
per injection (Gower et al., 1989). Control animals 
(shams) were injected in a similar way but only 
received 2lal of the vehicle solution per injection. 
After injections the pups were randomly distri- 
buted among the mother ats so that each mother 
nursed seven to eight pups. All experiments were 
terminated when the animals reached the age of 3 
months. 
Tissue preparation 
To study the effect of postnatal administration 
of AF64A on the development of the cholinergic 
innervation in the forebrain, the cholinergic fibres 
were stained by use of acetylcholinesterase (ACHE) 
histochemistry and in most of the cases also by 
immunocytochemistry for choline acetyltransferase 
(CHAT). For all (immuno)histochemical treat- 
ments, the animals were transcardially perfused 
with 3% paraformaldehyde, 0.05% glutaraldehyde 
and 0.2% saturated picric acid in 0.1 M-phosphate 
buffer (PB) at pH 7.4. The brains were dissected, 
stored overnight in 30% sucrose at 4°C and serially 
sectioned on a cryostat microtome at thicknesses of
16 and 30 ~tm. 
For AChE histochemistry, free-floating sections 
were postfixed for 12-24 h in 2.5% glutaraldehyde 
in 0.05 M-PB and stained according to the procedure 
as described by Hedreen et al. (1985). In short, 
this procedure included reactions in subsequent 
steps of acetylthiocholine, ammonium sulfide, 
sodium nitrate and silver nitrate, yielding a clear 
staining pattern of AChE-positive fibres. 
Immunocytochemical staining for ChAT and 
SOM started with pretreatment with 10% normal 
rabbit or normal goat serum, directly followed by 
exposure to goat anti-ChAT (Bruce et al., 1985) or 
rabbit anti-SOM28 (Benoit et al., 1982), respect- 
ively. The anti-ChAT antibody was kindly donated 
by Dr L. B. Hersh, the anti-SOM antibody was a gift 
of Dr R. E. Benoit. Then sections were incubated 
with rabbit anti-goat IgG or goat anti-rabbit 
IgG, followed by goat or rabbit peroxidase- 
antiperoxidase, respectively. All antibodies were 
diluted in phosphate-buffered saline (PBS) with 0.1% 
Triton X-100 (for further details on the procedures 
see Luiten et al., 1988, and Van der Zee et al., 1991). 
Protein kinase C subtype I was immunostained by 
using monoclonal antibody 36G9 against he puri- 
fied enzyme (Cazaubon et al., 1989). Incubation 
steps included 5% normal sheep serum, mouse IgG 
anti-PKC-I (l:200, overnight at 4°C), biotinylated 
sheep anti-mouse IgG (Amersham, 1:200, 2 h at 
room temperature) and horseradish peroxidase 
(HRP)-conjugated streptavidin (Amersham, 1: 200, 
2h at room temperature). The immunocom- 
plexes were visualized by standard reaction with 
diaminobenzidine (DAB) and hydrogen peroxide. 
lmmunoeytochemistry formAChR 
Muscarinic receptors were visualized with mono- 
clonal antibody M 35 raised against purified receptor 
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proteins (see Andr6 et al., 1987; Luiten et al., 1988; 
Van der Zee et al., 1989; Schrrder et al., 1990, for 
descriptions of procedures, characterization a d 
applications). For mAChR immunocytochemistry, 
animals were perfused with 300 ml fixative contain- 
ing 3% paraformaldehyde, 0.05% glutaraldehyde 
and 0.2% picric acid in 0.1 M-PB. The brains were 
dehydrated overnight in 30% sucrose olution and 
cut to 30 I~m frozen sections. The sections were pre- 
treated with 0.1% H202 and 5% normal rabbit 
serum, immediately followed by incubation with 
M35 (mouse IgM) overnight at 4°C. After rinsing, 
the sections were exposed to biotinylated rabbit 
anti-mouse IgM for 2 h at room temperature and 
subsequently o streptavidin conjugated with HRP, 
again for 2 h at room temperature. All incubations 
took place in PBS but without any addition of deter- 
gents. The HRP labels were finally stained with 
DAB and H202 in Tris buffer. 
Neurochemical determinations 
To avoid blood contamination f brain tissue, the 
rats were transcardially perfused with heparinized 
saline under pentobarbital naesthesia. The brain 
was rapidly removed from the skull and several brain 
areas were dissected out macroscopically: hippo- 
campus, parietal neocortex and corpus striatum; the 
activity of the two cholinergic marker enzymes 
ChAT and AChE was determined. For ChAT 
measurement, the method escribed by Brownstein 
et al. (1975) was followed. Briefly, the tissue samples 
were homogenized in 0.1 M-PB, pH 6.0. The final 
incubation volume of 40~tl contained 0.25M- 
NaCI, 0.1 mM-neostigmine, 12.5 mM-choline chlor- 
ide, 0.1% Triton X-100 and 1.25mM-[14C]acetyl 
coenzyme A (5 mCi/mmol, Amersham). After incu- 
bation at 37°C for 30 min, the samples were passed 
through DOWEX 1 (HCO3- , Serva, Heidelberg, 
FRG) for elimination of labelled acetyl coenzyme 
A. The activity of the enzyme was expressed in ~tmol 
acetylcholine synthesized per hour per 1 g protein of 
the sample. 
The activity of AChE was assayed with the 
colorimetric method of Ellman et al. (1961). The 
tissue samples were homogenized in 50 vol. 0.1 M 
PB, pH8.0, containing 1% Triton X-100. The 
enzyme activity was expressed in lxmol/min per g 
protein. For protein measurement, the method of 
Lowry et al. (1951) was used. 
Biochemical determination of muscarinic binding 
sites 
The number of muscarine-like binding sites was 
measured by a modified method of Yamamura 
and Snyder (1974). Briefly, the brain tissue was 
homogenized in 20 vol. ice-cold sucrose (0.32 M) and 
centrifuged at 1000g for 10min. The supernatant 
was centrifuged again at 17,000 g for 15 min and 
the pellet resuspended and homogenized in 0.32 
M-sucrose. Aliquots of this homogenate (protein 
contents varied between 0.15 and 0.20mg) were 
incubated in the presence of a saturating con- 
centration (2riM) of [3H]quinuclidinyl benzilate 
([3H]QNB; 42Ci/mmol, Amersham, UK) in a 
50 mM-sodium-phosphate buffer, pH = 7.4 at 25°C 
for 60 min. After incubation, the samples were fil- 
tered on Whatman GF/B glass microfibre papers, 
which were washed twice with 10 ml ice-cold PB. 
The bound radioactivity retained on the filters was 
counted with a liquid scintillation spectrometer 
and corrected for non-specific binding, which was 
measured in the presence of 10 -4 M-atropine. The 
protein content was quantified according to Lowry 
et al. (1951). 
RESULTS 
All cases that received bilateral intraventricular 
injections with the cholinotoxin AF64A at post- 
natal day 8 revealed a very strong and consistent 
reduction of cholinergic fibres in the hippocampus 
(Fig. 1). This reduction was visualized both by 
AChE and by ChAT staining of fibres and affected 
all areas from cornu ammonis (CA) and dentate 
gyrus (DG). It appeared, however, that he choliner- 
gic denervation i  the DG was slightly stronger than 
in the CA. This may be explained by a relatively 
larger proportion of axons traversing the stratum 
oriens (Or) being less sensitive to AF64A than the 
larger proportion of terminals in the dentate at the 
time of the lesion. The general reduction ofcholiner- 
gic fibres in the hippocampus only showed alimited 
variation. In the majority of cases, the neurotoxin 
treatment resulted in a fibre decrement indicated as 
'moderate'. In some cases, there was an almost otal 
depletion of cholinergic fibres, which was notably 
the case in the DG. In the 'moderate' lesion cases, 
some non-specific tissue necrosis was observed near 
the site of the needle track. This non-specific 
damage was accompanied by a slight reduction in 
size of the fimbria-fornix and an enlargement of the 
dorsal part of the lateral ventricle. In some more 
heavily lesioned cases also, some damage to the CA 3 
area of the dorsal hippocampus occurred close to 
the injection eedle track. Such damage, however, 
did not involve the CAI region. Furthermore, as a 
general observation it was noted that the lesion 
effects on cholinergic nnervation development w re
stronger in the dorsal hippocampus a compared to 
the ventral or temporal hippocampal areas. This 
difference most likely is to be related to the dorsal 
and anterior position of the neurotoxin i jection in 
the ventricle. In contrast o the consistently arge 
decrease in cholinergic fibre density in the hippo- 
campus, there were no such effects observed in the 
neocortex nor in the striatum. 
Similar results were obtained when assessing 
cholinergic activity by measuring the ACh syn- 
thesizing and degrading enzymes by means of 
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Fig. 1. Photomicrographs s owing the effects of early postnatal intracerebroventricular injections of AF64A on cholinergic innervation f
the hippocampus in adulthood. (A) and (B) illustrate cholinergic fibres stained for acetylcholinesterase activity in the cornu ammonis~ in 
controls (A) and in lesioned cases (B). Lesion effects xemplified for the dentate gyrus are indicated in (C) and (D) by dark-field 
illumination of fibres tained for choline acetyltransferase immunoreactivity in controls (C) and AF64A-lesioned cases (D). Scale bar in all 
figures = 50 ~tm. 
biochemical assays in tissue homogenates. Both 
enzymatic markers revealed a highly significant 
decrement of approximately 60% in adulthood in 
the hippocampi of AF64A-lesioned animals (Fig. 2) 
but not in the neocortex and striatum. 
To establish the effect of an early postnatal and 
persistent cholinergic lesion in the hippocampus on 
development of postsynaptic cholinergic receptors, 
the presence of muscarinic receptors was investi- 
gated by binding of ligands and antibodies 
to mAChR. Immunoreactivity of anti-muscarinic 
monoclonal antibody M35 displayed a strikingly 
lower level of antibody binding in the AF64A- 
treated cases in adulthood. Similar to the effects 
found on cholinergic fibre markers, both CA and 
DG reacted with equally low levels of immuno- 
staining, both of the cell bodies in the granular (Gr) 
and pyramidal (Pyr) cell layers, and in the DG 
molecular (mol) and CA dendritic layers. On the 
other hand, there was no decrease in immuno- 
staining in interneurons situated close to the 
pyramidal cell layer or in the dentate hilar region. It 
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Fig. 2. Activities of the cholinergic marker enzymes choline 
acetyltransferase (CHAT) and acetylcholinesterase (ACHE) in 
hippocampus, parietal cortex and striatum in controls and rats 
postnatally injected with 2 nmol AF64A in the lateral ventricles. 
In the hippocampus both enzyme activities are significantly 
decreased after AF64A treatment (**P < 0.001). 
even appeared that those cells in the AF64 cases 
stained somewhat stronger (Figs 3, 4). Again, the 
lesion effects were confined to the hippocampus. 
Identical effects of the perinatal lesion on 
muscarinic receptors were established by binding of 
the tritiated muscarinic ligand [3H]QNB in hippo- 
campal tissue homogenates. A consistently and 
significantly lower level of 60% to controls was 
measured in the lesioned hippocampi (Fig. 5). 
In spite of the dramatic and persistent depletion 
of cholinergic innervation of CA and DG, there was 
no obvious change in the long-term development 
of the SOM-immunoreactive interneurons of the 
hippocampus. These SOM interneurons character- 
istically made up a part of the interneuron popu- 
lation in the hilar (Hi) region of the DG and the 
stratum oriens (Or) of the CA. Notwithstanding the 
apparent cholinergic input to these neurons, there 
was no clear change in cell number nor in the SOM 
projections to the molecular layers of the hippocam- 
pus. In four control cases and five representative 
AF64A lesioned cases, the numbers of SOM- 
immunoreactive c lls were quantified in the dorsal 
hippocampus at AP level 5.20-5.40 mm anterior 
to interaural. SOM-immunoreactive n urons were 
counted in three transverse sections per case and 
calculated as average numbers of cells per mm 2 
tissue in dentate hilus and CAI stratum oriens. 
Oriens and hilus in controls contained 98.4 (+ 15.1) 
and 73.1 ( + 2.4) cells/mm 2,respectively, while these 
regions in the AF64A-treated animals contained 
101.8 (+13.8) and 66.4 (+3.7) cells/mm 2. This 
means an increase of 3% SOM cells in the oriens 
and a decrease of 9% in the hilus in the AF64A cases 
relative to controls. These differences are not sig- 
nificant. Similar observations were made on PKC-I 
immunoreactivity of the hippocampus. PKC type I, 
which for a considerable part is colocalized with 
M35, revealed patterns that were only slightly 
influenced by the AF64A treatment. The PKC-I 
activity was notably strong in the pyramidal cells 
of the CA and their apical dendrites, whereas the 
activity level is only minor in the DG granule cells. 
This pattern was similar in the AF64 cases, although 
a slightly less intense staining in the dendritic region 
of the stratum radiatum was observed. 
DISCUSSION 
The present data show that destruction of ingrowing 
cholinergic fibres in the hippocampus in the early 
postnatal period results in a permanent cholinergic 
denervation. This cholinergic depletion coincides 
with a suppressed muscarinic acetylcholine r ceptor 
expression i  the postsynaptic cholinoceptive prin- 
cipal neurons of the hippocampus, whereas this was 
not the case in some cholinoceptive interneurons. 
The cholinergic breakdown after intracerebroven- 
tricular injection with the cholinotoxin AF64A is 
a phenomenon well-documented with anatomical, 
histochemical nd biochemical data (Gafil et al., 
1986; Kfisa et al., 1986; Gower et al., 1989). AF64A 
acts at the high-affinity choline uptake mechanism 
at cholinergic nerve endings (Chrobak et ai., 1989). 
It was shown by various authors that i.c.v, injections 
of low doses of 5 nmol AF64A in the lateral 
ventricle selectively destroy presynaptic cholinergic 
terminals (Gafil et al., 1986; K~sa et al., 1986; 
Gower et al., 1989) and by retrograde transport via 
axonal pathways affect he cell bodies of origin in 
the medial septum complex (Gafil et al., 1986). The 
specificity of AF64A as a cholinotoxin, however, is 
still a matter of debate. AF64A injected directly into 
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Fig. 3. Immunostaining to muscarinic receptors in the cornu ammonis~ at low (A,B) and higher magnifications (C,D) in controls (A,C) and 
after AF64A lesion (B,D). Note the decreased immunostaining  the pyramidal ceils in the lesioned cases, whereas interneuron staining 
(arrows) remains unchanged. Scale in A,B: 100 lam; in C,D: 25 lam. 
brain tissue not only acts as a cholinotoxin but 
causes damage to identified non-cholinergic systems 
as well, even when low doses of 0.05 nmol are 
applied (Levy et al., 1984; Kozlowski and Arbogast, 
1986; McGurk et al., 1987). Higher AF64A con- 
centrations of 3 nmol or more, when injected into 
the lateral ventricles, also may induce damage to 
non-cholinergic systems and result in tissue necrosis 
(Jarrard et al., 1984; Ga~l et al., 1986; Potter et al., 
1986; H6rtnagl et al., 1987). As was also the case in 
our own experiments, AF64A close to the site of 
injection resulted in local tissue damage and ven- 
tricle enlargement that cannot be attributed to a 
specific anti-cholinergic action of this neurotoxin. 
However, when applied in relatively low doses of 
2 nmol or less, combined with administration via 
the ventricular system (K~isa et al., 1986), the non- 
specific damage appears to be limited to the direct 
vicinity of the injection locus. As such, observations 
on the anti-cholinergic effects of the AF64A injec- 
tions should be carried out on brain regions at a safe 
distance from the injection site where no apparent 
necrosis can be detected. Furthermore, it was pre- 
viously demonstrated that the hippocampus reveals 
the highest sensitivity to AF64A (Fisher et al., 1982; 
Gower et al., 1989). In the present study as well, the 
damage after low-dose i.c.v, injections of 2 nmol 
AF64A remains confined to the hippocampus and 
has no or only minor effects on other forebrain areas 
(Fisher et al., 1982; Kfisa et al., 1986; Gower et al., 
1989). 
Apart from the toxic effect of AF64A on presynap- 
tic structures, everal investigators eported lack of 
changes in postsynaptic acetylcholine r ceptors as 
studied by ligand binding techniques (Fisher et al., 
1982; K~isa et al., 1986). The absence of effects of 
AF64A treatment on cholinergic receptor affinity or 
expression i their experiments, however, is not very 
surprising. Similar lack of effects on muscarinic 
receptors i reported after fimbria-fornix and medial 
septum lesions (S~bato et al., 1981) and in patho- 
logical cholinergic breakdown as in Alzheimer's 
disease (Giacobini et al., 1988; Geula and Mesulam, 
1989; Luiten et al., 1989; Schr6der et al., 1991). 
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Fig. 4. Immunoreactivity to muscarinic a etylcholine receptor with antibody M35 in the dentate gyrus granular and molecular layers in 
controls (A,C) and AF64A-lesioned rats (B,D). As in the cornu ammonis, region, decreased staining islimited to the granular cells, while 
the interneurons stain as normal. Bar inA,B: 50 I~m; in C,D: 25 ~m. 
The difference with the currently used experi- 
mental set-up, however, is the fact that in our 
case mild (2 nmol) i.c.v, injections of AF64A were 
applied at early postnatal periods. In this period the 
cholinotoxin interferes with the process of ingrowth 
of cholinergic fibres from their subcortical sources 
in medial septum complex to their hippocampal 
target cells (Milner et al., 1983; Nyakas et al., 1987, 
1989). At the time of lesion at postnatal day 8, the 
cholinergic fibres start to invade the hippocampal 
formation and the process of synaptogenesis is only 
in its primary stages (Kolb and Whishaw, 1989; 
Mattson, 1989). So the lesion coincides with the 
period when most synapses have not yet formed or 
when stabilization of functional contacts has not yet 
occurred (Berry, 1974; Kolb and Whishaw, 1989; 
Vaughn, 1989). Maturation of the cholinergic 
septo-hippocampal connection continues even up 
to 50 days after birth (Sofroniew et al., 1987). 
In the early period of postnatal development, there 
is a gradually increasing expression of muscarinic 
receptors, which has been studied by muscarinic 
ligand binding and by gene expression (Coyle and 
Yamamura, 1976; Rotter et al., 1979; Large et al,, 
1985; Fiedler et al., 1987; Noguchi et al., 1988; 
Pinkas-Kramarski et al., 1989). The ontogeny of 
muscarinic receptors parallels the development of 
secondary messenger systems that are linked to 
mAChRs (Strosberg, 1991), like phosphatidyl- 
inositol turnover (Large et al., 1985; Balduini et al., 
1987) and PKC activity (Nakahara et al., 1989; 
Sposi et al., 1989). It was also demonstrated that 
muscarinic receptors are functionally coupled to 
their second messenger systems, before functional 
synaptic ontacts are established (Large et al., 1985; 
Balduini et al., 1987). Since the current experiment 
is characterized by cholinergic fibre destruction by 
AF64A before or during synapse formation, the 
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Fig. 5. Histograms showing levels of binding of the labelled 
muscarinic antagonist quinuclidinyl benzilate (QNB) in hippo- 
campus, cortex and striatum at the age of 3 months. The total 
labelling (Bin,,) in the hippocampus is significantly reduced 
(**P < 0.01) in the perinatally AF64A-lesioned animals. 
effects on muscarinic receptor development and 
expression are probably explained by absence of 
presynaptic trophic influence on postsynaptic 
receptor stabilization. This implies that the timely 
arrival of the presynaptic bouton is extremely essen- 
tial for further development and maturation of the 
muscarinic receptor complex (Nyakas et al., 1989; 
Represa et al., 1989), which contrasts with the lack 
of such presynaptic influence on postsynaptic 
muscarinic receptor expression and function in 
adulthood and aging. In other words, these findings 
indicate that presynaptic cholinergic input is essen- 
tial for the formation of synaptic integrity, but is not 
relevant for the maintenance ofmuscarinic receptor 
function after synaptogenesis. The latter phenom- 
enon is also illustrated by recovery of functional 
deficits by application of muscarinic agonists in 
AF64A-lesioned animals (Nakahara et al., 1989). 
In the current study it was also established that 
the persistent cholinergic denervation had no or 
only minor effects on the immunoreactivity o 
PKC-I. This was somewhat surprising since the M 1 
subtype of the muscarinic receptor is intimately 
linked to phosphatidylinositide turnover and PKC 
activation (Haga et al., 1990; Strosberg, 1991). 
This coupling of mAChR and PKC-I was recently 
also demonstrated by colocalization studies with 
double-label immunocytochemistry (Van der Zee et 
al., 1990). On the other hand, it has been reported 
that in early ontogeny only the II- and III-subtypes 
of PKC are expressed, whereas the gene of PKC-I 
becomes activated much later in development 
(Sposi et al., 1989). Furthermore, we should realize 
the PKCs are associated not only with cholinergic 
input, but also with a large number of receptors for 
other input sources to hippocampal principal cells, 
such as glutamate, serotonin, orepinephrine and a 
variety of neuropeptides and hormones (Strosberg, 
1991). It was also striking that the permanent 
cholinergic breakdown apparently did not exert 
much influence on the mAChR immunoreactivity, 
nor on the transmitter content of hippocampal 
interneurons such as the SOM cell group. SOM cells 
in the hippocampus were shown to receive a partly 
cholinergic medial septal input and half of the SOM 
neurons are provided with muscarinic receptors 
(Yamano and Luiten, 1989; Van der Zee et al., 
1991). We do not known, however, whether the 
M35-immunoreactive interneurons surviving after 
cholinergic lesion in the present study are also 
SOMergic cells. The fact that SOMergic neurons 
remain unaffected by the developmental cholinergic 
lesion indicates that its cholinergic afference is not 
essential for its neuronal development i  adulthood. 
The observation that SOM immunoreactivity does 
not change after chronic cholinergic denervation 
induced by AF64A treatment corroborates pre- 
vious findings that SOM-immunoreactivity in 
the hippocampus remained unaltered after septo- 
hippocampal lesions in adult hood (Pierotti and 
Simpson, 1986). The condition of SOM after 
AF64A lesions, however, is dependent on the post- 
lesion survival time. H6rtnagl et al. (1990) recently 
reported that SOM concentrations in the hippo- 
campus how a transient reduction after cholinergic 
denervation by AF64A, and recover to control 
levels 2 weeks after lesion. The relatively strong M35 
immunoreaction in the interneurons shows that the 
suppressed maturation of mAChR in the principal 
cells is a rather cell-specific effect with yet unknown 
underlying mechanisms. 
We should bear in mind, however, that AF64A 
lesions may also influence other transmitter or 
neuroactive systems in the developing hippocam- 
pus. We cannot entirely rule out that AF64A may 
have affected the development of monoaminergic 
systems in the hippocampus. In this respect it has 
been reported that higher concentrations of AF64A 
injections induce a transient reduction of serotonin 
levels (Potter et al., 1986), which may play a role in 
the maturation of hippocampal tissue (Hamon et 
al., 1989). 
A further question we wish to answer is the 
assumed relationship between growth-retarded 
cholinergic development after perinatal hypoxia, 
and the causal mechanisms oflearning defects after 
such hypoxic events. The current experiments, 
albeit with an exaggerated perinatal cholinergic 
lesion, clearly indicate the detrimental effects of the 
cholinergic lesion on muscarinic receptor expres- 
sion. It may be concluded also that less dramatic 
suppression of cholinergic hippocampal innerva- 
tion will probably have a suppressive influence on 
mAChR development (see also Represa et al., 
1989). Such a muscarinic receptor suppression 
will likely add to the persistent cognitive decline 
observed after perinatal hypoxic brain damage 
(Hershkowitz et al., 1983; Nyakas et al., 1989, 
1991). 
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